arXiv Computer Vision

A Multimodal Dataset for Survival Prediction in Resected Pancreatic Ductal Adenocarcinoma

The paper introduces a multimodal dataset for survival prediction in resected pancreatic ductal adenocarcinoma, comprising 302 patients, 446 H&E whole-slide images, clinicopathological variables, targeted sequencing data for 154 patients, and overall survival outcomes. The authors evaluated fourteen survival‑prediction models, finding that a Ridge Cox regression on numeric clinicopathological variables achieved the highest concordance (≈0.65), while multimodal fusion of image and molecular data reached 0.619. These benchmarks provide a foundation for future research and external validation using this pancreas‑specific dataset.

arXiv AI
Sep 21

MIST: Multimodal Survival Prediction with Genomic-Guided Histology Attention

MIST is a multimodal survival prediction framework that fuses whole-slide images and genomic profiles by representing genomic features as tokens that query histology context tokens derived from a foundation model. The architecture enriches molecular information with histology context before survival prediction, avoiding late-stage merging of separately encoded modalities. Training incorporates discrete-time survival prediction, genomic feature masking, WSI dropout, and contrastive alignment, and demonstrates improved external C-index across colon, renal, lung, and glioblastoma cohorts compared to standard fusion baselines.

By Muhammet Sami Yavuz, Sabri Mustafa Kahya, Richard R. Chen, Jana Lipkova, Benedikt Wiestler
arXiv Machine Learning
Jul 24

Multimodality Stacking with Blockwise missing values and application to the PIONeeR biomarkers study for prediction of resistance to immunotherapy

arXiv:2605. 25050v2 Announce Type: replace-cross Abstract: Integrating multimodal datasets in clinical oncology is frequently hindered by high dimensionality and blockwise missingness, where entire data sources are unavailable for specific patient subsets.

By Mohamed Boussena, Florence Monville, Jacques Fieschi-Meric, Frederic Vely, Pierre Milpied, Julien Mazieres, Maurice Perol, Eric Vivier, Laurent Greillier, Fabrice Barlesi, Sebastien Benzekry
arXiv AI
Jun 17

Probing, Fusion, and Trustworthiness: A Systematic Evaluation of Foundation Model Representations for Multimodal Cancer Analysis

arXiv:2606. 17115v1 Announce Type: cross Abstract: Foundation models (FMs) have emerged as powerful representation extractors for medical data, yet their generalizability to datasets under distribution shift remains underexplored.

By Jingyu Hu, Giuseppe Tripodi, Reed Naidoo, Sarah F. McGough, Tapabrata Chakraborti
arXiv Computation and Language
1d ago

Large Language Models are Approximate Survival Estimators

arXiv:2609.38181v1 Announce Type: new Abstract: Survival analysis estimates time-to-event outcomes from patient covariates and is widely used for medical risk assessment. Patients seeking prognostic...

By Juan M Zambrano Chaves, Peniel Argaw, Risa Ueno, Carlo Bifulco, Kristina Young, Rom Leidner, Tristan Naumann, Hoifung Poon
arXiv Computer Vision
Sep 7

Real-World Multi-Modal and Longitudinal Lung Cancer Dataset

The paper presents a newly curated, multi-center, multi-modal, and longitudinal lung cancer dataset comprising 1,365 patients with whole-slide images, CT scans, PET scans, structured clinical data, transcriptomics, and follow-up information. The dataset features substantial, non-uniform missingness across modalities, making it ideal for evaluating robust multi-modal fusion strategies. Benchmarks on 12‑month overall survival, disease‑specific survival, and longitudinal hazard prediction demonstrate that integrating complementary modalities consistently outperforms uni-modal approaches, even under severe missing data.

By Rita Cordeiro Mendes, Maria Rita Fonseca Verdelho, Carlos Santiago, Catarina Barata
arXiv AI
Jul 16

Multimodal Assessment of Pancreatic Cancer Resectability Using Deep Learning

arXiv:2607. 13826v1 Announce Type: cross Abstract: Accurate determination of pancreatic ductal adenocarcinoma (PDAC) resectability relies on evaluating how the tumor interacts with major peripancreatic vessels on CT imaging, yet expert assessment often shows substantial variability.

By Vincent Ochs, Christoph Kuemmerli, Florentin Bieder, Julia Wolleb, Joel L. Lavanchy, Julia Ruppel, Jan Liechti, Stephanie Taha-Mehlitz, Christian Andreas Nebiker, Beat Mueller, Giuseppe Kito Fusai, Joerg-Matthias Pollok, Anas Taha, Philippe C. Cattin, Sebastian Staubli
arXiv Computer Vision
Aug 25

CHIMERA Challenge: Biochemical Recurrence Prediction in Prostate Cancer Patients using multimodal datasets

arXiv:2608.21497v1 Announce Type: cross Abstract: Biochemical recurrence (BCR), defined as any detectable prostate-specific antigen level after prostatectomy with confirmatory elevation, is widely us...

By Robert N. Spaans, Catherine Chia, Tongjie Wang, Adam Kowalewski, Parandzem Khachatryan, Domingos Oliveira, Khrystyna Faryna, Jean-Paul A. van Basten, Geert Litjens, Nadieh Khalili